Addex Therapeutics Ltd Share Price Xetra
Equities
APE
CH0029850754
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | 20M 22.04M 20.48M 1.84B | Capitalization | 9.41M 10.37M 9.64M 866M |
---|---|---|---|---|---|
Net income 2024 * | -6M -6.61M -6.15M -552M | Net income 2025 * | 13M 14.32M 13.31M 1.2B | EV / Sales 2024 * | - |
Net cash position 2024 * | 362K 399K 371K 33.33M | Net cash position 2025 * | 7.23M 7.96M 7.4M 664M | EV / Sales 2025 * | 0.11 x |
P/E ratio 2024 * |
-0.82
x | P/E ratio 2025 * |
0.35
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 50.48% |
Latest transcript on Addex Therapeutics Ltd
Managers | Title | Age | Since |
---|---|---|---|
Tim Dyer
FOU | Founder | 56 | 01/02/01 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 38 | 01/17/01 |
Vincent Lawton
CHM | Chairman | 75 | 16/09/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jake Nunn
BRD | Director/Board Member | 53 | 01/18/01 |
Tim Dyer
FOU | Founder | 56 | 01/02/01 |
Vincent Lawton
CHM | Chairman | 75 | 16/09/16 |
1st Jan change | Capi. | |
---|---|---|
+22.56% | 46.71B | |
+48.83% | 41.8B | |
-1.51% | 41.52B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
-0.14% | 12.14B | |
-0.47% | 12.08B | |
+26.45% | 11.98B |